Aspiriant Defensive Allocation FundRMDFX
Type
Mutual fund
Peer group
Allocation
Net assets
$1.1B
Expense ratio
5.15%
1-year return
+18.0%
3 years, a year
+11.4%
5 years, a year
+6.3%
Holdings
14
What it aims to do.
The Aspiriant Defensive Allocation Fund (the Fund or Defensive Allocation Fund) seeks to achieve long-term investment returns with lower risk and lower volatility than the stock market, and with relatively low correlation to stock and bond market indexes.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| GMO Benchmark-Free Allocation Fund | 25.94% |
| Wilshire Bridgewater Managed Alpha (Ireland) Fund | 12.58% |
| IAU iShares Gold Trust | 8.79% |
| Lazard Global Investment Funds plc - Lazard Rathmore Alternative Fund | 6.95% |
| Victory Pioneer Multi-Asset Income Fund | 6.63% |
| JPMorgan Global Allocation Fund | 6.19% |
| Eaton Vance Global Macro Absolute Return Advantage Fund | 6.11% |
| Millennium International Ltd. | 6.01% |
| GMO Investments ICAV - GMO Equity Dislocation Investment Fund | 5.78% |
| Elliott Associates LP | 4.34% |
More on RMDFX.
- RMDFX overview
- RMDFX holdings
- RMDFX risk
- RMDFX costs
- RMDFX money in and out
- RMDFX share classes
- Compare RMDFX with other funds
Returns after fees, from the fund's SEC filings up to Mar 2026. Past returns are not a promise. Not financial advice.